Terumo BCT, Inc. is a global leader in blood component, therapeutic apheresis, and cell therapy technologies, serving healthcare providers in over 150 countries from its Colorado headquarters.
Import Shipments
Distribution Centers
Annual Revenue
Founded
Terumo BCT is likely advancing automation in blood collection, expanding cell therapy technologies, and strengthening global supply chains to meet rising healthcare demands.
Launch of new automated blood and plasma collection systems
Strategic efforts to expand market presence and reach new customer segments.
Implementation of advanced technologies to improve service delivery and customer experience.
Terumo BCT, Inc. develops and manufactures innovative medical devices, software, and services that enable the collection, preparation, and processing of blood and cells for therapeutic use. The company’s technologies are vital for blood transfusions, plasma collections, and emerging cell and gene therapies. With a strong focus on automation, innovation, and global access to care, Terumo BCT collaborates closely with healthcare providers to improve patient outcomes. Its global network includes seven manufacturing sites and a robust distribution system, ensuring reliable delivery of products and solutions.
Lakewood, Colorado, USA
1965
Private company
